News & Events
New study shows that early use of high efficacy treatment for MS improves long term disability outcomes,…
In a recent study, scientists have shown that people with MS who have food allergies are more…
The Global MS Research Booster Award provides funding for scientists who aim to identify the cause(s) of…
The 'My Invisible MS' toolkit is now available online
A new study supported by MS Australia suggests that adventure and challenge can help people manage an…
MSIF’s Atlas of MS with new data on the number of people living with MS across the…
The MS Society of India celebrated India MS Day with a national bike rally. Learn more about…
The UK MS Society met up with Brooklyn rapper and record producer Masta Ace to talk about…
EMA conducts safety review of alemtuzumab (Lemtrada)
FDA approves cladribine for people with relapsing forms of MS and active secondary progressive MS
FDA approves the drug Siponimod, to treat people with active secondary progressive MS